QGL · Class II — Moderate Risk (510(k) clearance required) · Neurology · 21 CFR 882.5898
Classification
FDA Product Code
QGL
Device class
Class II — Moderate Risk (510(k) clearance required)
Regulation
21 CFR 882.5898
Review panel
NE
Medical specialty
Neurology
Submission type
1
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
N
Definition
A transcutaneous electrical nerve stimulator for Attention Deficit Hyperactivity Disorder (ADHD) is a prescription device that stimulates transcutaneously or percutaneously through electrodes placed on the forehead.